X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare India Infoline with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IIFL HOLDINGS vs INDOCO REMEDIES - Comparison Results

IIFL HOLDINGS    Change

India Infoline is one of the oldest and leading players in the Indian broking services space. Besides offering the entire gamut of financial services covering investment products ranging from equities and derivatives, commodities and portfolio manage... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IIFL HOLDINGS INDOCO REMEDIES IIFL HOLDINGS/
INDOCO REMEDIES
 
P/E (TTM) x 28.8 44.1 65.3% View Chart
P/BV x 7.6 2.8 270.9% View Chart
Dividend Yield % 0.6 0.8 73.6%  

Financials

 IIFL HOLDINGS   INDOCO REMEDIES
EQUITY SHARE DATA
    IIFL HOLDINGS
Mar-16
INDOCO REMEDIES
Mar-17
IIFL HOLDINGS/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs226360 62.6%   
Low Rs160249 64.3%   
Sales per share (Unadj.) Rs125.9119.0 105.7%  
Earnings per share (Unadj.) Rs16.18.4 193.1%  
Cash flow per share (Unadj.) Rs18.215.2 119.7%  
Dividends per share (Unadj.) Rs4.251.60 265.6%  
Dividend yield (eoy) %2.20.5 419.6%  
Book value per share (Unadj.) Rs92.270.7 130.5%  
Shares outstanding (eoy) m316.5492.15 343.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.52.6 59.9%   
Avg P/E ratio x11.936.4 32.8%  
P/CF ratio (eoy) x10.620.0 52.9%  
Price / Book Value ratio x2.14.3 48.5%  
Dividend payout %26.319.1 137.6%   
Avg Mkt Cap Rs m61,06128,083 217.4%   
No. of employees `000NA6.0 0.0%   
Total wages/salary Rs m7,0452,167 325.1%   
Avg. sales/employee Rs ThNM1,817.0-  
Avg. wages/employee Rs ThNM359.0-  
Avg. net profit/employee Rs ThNM127.7-  
INCOME DATA
Net Sales Rs m39,84010,968 363.3%  
Other income Rs m11640 292.7%   
Total revenues Rs m39,95711,007 363.0%   
Gross profit Rs m25,7711,565 1,647.1%  
Depreciation Rs m661633 104.4%   
Interest Rs m16,80062 27,053.1%   
Profit before tax Rs m8,426909 926.6%   
Minority Interest Rs m-4360-   
Prior Period Items Rs m-420-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,836139 2,045.0%   
Profit after tax Rs m5,112771 663.3%  
Gross profit margin %64.714.3 453.4%  
Effective tax rate %33.715.3 220.7%   
Net profit margin %12.87.0 182.6%  
BALANCE SHEET DATA
Current assets Rs m122,9035,725 2,146.8%   
Current liabilities Rs m96,5345,454 1,769.9%   
Net working cap to sales %66.22.5 2,681.6%  
Current ratio x1.31.0 121.3%  
Inventory Days Days362 4.9%  
Debtors Days Days5472 74.8%  
Net fixed assets Rs m4,8055,307 90.5%   
Share capital Rs m633184 343.5%   
"Free" reserves Rs m20,7736,331 328.1%   
Net worth Rs m29,2006,516 448.2%   
Long term debt Rs m90,2031,323 6,817.6%   
Total assets Rs m228,76611,970 1,911.2%  
Interest coverage x1.515.6 9.6%   
Debt to equity ratio x3.10.2 1,521.2%  
Sales to assets ratio x0.20.9 19.0%   
Return on assets %9.67.0 137.7%  
Return on equity %17.511.8 148.0%  
Return on capital %20.712.4 167.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m01,141 0.0%   
Net fx Rs m03,366 0.0%   
CASH FLOW
From Operations Rs m-541886 -61.0%  
From Investments Rs m-6,707-1,706 393.2%  
From Financial Activity Rs m5,2491,316 398.9%  
Net Cashflow Rs m-1,999497 -402.6%  

Share Holding

Indian Promoters % 30.7 59.2 51.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.8 12.5 6.4%  
FIIs % 44.4 6.0 740.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 24.2 22.4 108.0%  
Shareholders   27,982 12,805 218.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IIFL HOLDINGS With:   INDIABULLS FIN. SER.  NALWA SONS INV  CHOLAMANDALAM INVEST.  REDINGTON (INDIA)  RELIGARE ENT.  



Today's Market

OPEC Meeting; Upcoming IPOs; IDBI Bank, Emami among Top Stocks in Action Today(Pre-Open)

Indian share markets edged up on Friday with Nifty 50 closing above 10,800-levels, even as broader global markets remained weak.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3%

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

ICICI Securities IPO: Will the Brokerage Shine If Markets Don't? (IPO)

Mar 22, 2018

Is the IPO of one of India's first online brokerage firm, ICICI Securities, worth applying for?

Shriram Trans Fin: Expansion on Track Driven by Brisk Demand and Strong Earnings (Quarterly Results Update - Detailed)

Feb 16, 2018

Shriram Transport Finance puts up a strong performance on robust demand and falling credit costs.

HDFC: Listing Gains Mask Healthy Growth and Asset Quality (Quarterly Results Update - Detailed)

Feb 7, 2018

Windfall listing gains utilised to shore up provisions and strengthen balance sheet further.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IIFL HOLDINGS SHARE PRICE


Jun 22, 2018 (Close)

TRACK IIFL HOLDINGS

  • Track your investment in IIFL HOLDINGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IIFL HOLDINGS 8-QTR ANALYSIS

COMPARE IIFL HOLDINGS WITH

MARKET STATS